Abstract |
The conventional prophylactic vaccines for human papillomavirus (HPV) efficiently prevent infection with high-risk HPV types, but they do not promote therapeutic effects against cervical cancer. Previously, we developed HPV16 E7-expressing Lactobacillus casei (L. casei-E7) as a therapeutic vaccine candidate for cervical cancer, which induces antitumor therapeutic effects in a TC-1 murine cancer model. To improve the therapeutic effect of L. casei-E7, we performed co-treatment with poly-gamma-glutamic acid (γ- PGA), a safe and edible biomaterial naturally secreted by Bacillus subtilis. We investigated their synergistic effect to improve antitumor efficacy in a murine cancer model. The treatment with γ- PGA did not show in vitro cytotoxicity against TC-1 tumor cells; however, an enhanced innate immune response including activation of dendritic cells was observed. Mice co-administered with γ- PGA and L. casei-E7 showed significantly suppressed growth of TC-1 tumor cells and an increased survival rate in TC-1 mouse models compared to those of mice vaccinated with L. casei-E7 alone. The administration of γ- PGA markedly enhanced the activation of natural killer (NK) cells but did not increase the E7-specific cytolytic activity of CD8+ T lymphocytes in mice vaccinated with L. casei-E7. Overall, our results suggest that oral administration of γ- PGA induces a synergistic antitumor effect in combination with L. casei-E7.
|
Authors | Eunjin Kim, Jihyun Yang, Moon-Hee Sung, Haryoung Poo |
Journal | Journal of microbiology and biotechnology
(J Microbiol Biotechnol)
Vol. 29
Issue 9
Pg. 1444-1452
(Sep 28 2019)
ISSN: 1738-8872 [Electronic] Korea (South) |
PMID | 31387341
(Publication Type: Journal Article)
|
Chemical References |
- Adjuvants, Immunologic
- Cancer Vaccines
- Papillomavirus E7 Proteins
- Papillomavirus Vaccines
- oncogene protein E7, Human papillomavirus type 16
- poly(gamma-glutamic acid)
- Polyglutamic Acid
|
Topics |
- Adjuvants, Immunologic
(administration & dosage, pharmacology)
- Administration, Oral
- Animals
- Cancer Vaccines
(administration & dosage, genetics, immunology)
- Cell Survival
- Cells, Cultured
- Dendritic Cells
(immunology)
- Female
- Immunity, Innate
(drug effects)
- Killer Cells, Natural
(immunology)
- Lacticaseibacillus casei
(genetics)
- Lymphocyte Activation
(drug effects)
- Mice
- Mice, Inbred C57BL
- Papillomavirus E7 Proteins
(genetics, immunology)
- Papillomavirus Vaccines
(administration & dosage, genetics, immunology)
- Polyglutamic Acid
(administration & dosage, analogs & derivatives, pharmacology)
- RAW 264.7 Cells
- Uterine Cervical Neoplasms
(prevention & control)
- Xenograft Model Antitumor Assays
|